Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SUCCESS: Seretide in Moderate and Severe Persistent Asthma
NCT00480649Phase 4Completed
- Sponsor
- GSK
- Start
- Jan 2004
- Primary completion
- Sep 2005
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of salmeterol, fluticasone propionate in asthma, sponsored by GSK. Started Jan 2004; status: completed.
02
Drugs
salmeterolfluticasone propionate
03
Conditions
asthma
Beyond the preview
Go deeper on NCT00480649.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00480649.